Pharmacokinetics and pharmacodymanics study of doctaxel in patients with non-small cell lung cancer

Pharmacokinetics and pharmacodymanics study of doctaxel in patients with non-small cell lung cancer - PK/PD study of doctaxel in patients with NSCLC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014701

Enrollment

Registered

2014-07-31

Start date

2014-08-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Pathologically confirmation of non small cell lung cancer 2) Administration of docetaxel is planned 3) Aged 20 or more 4) Written informed consent

Exclusion criteria

Exclusion criteria: Patients with interstitial pneumonitis identified by chest X-ray

Design outcomes

Primary

Measure	Time frame
Correlation between unbound docetaxel concentration and age	—

Countries

Japan

Contacts

Public ContactHirotsugu Kenmotsu

Shizuoka cancer center Division of Thoracic Oncology

h.kenmotsu@scchr.jp055-989-5222

Outcome results